🔎 Trials Near Me

Hjem › Galleveiskreft (kolangiokarcinom) › Illinois

Kliniske studier for Galleveiskreft (kolangiokarcinom) i Illinois

8 studier for Galleveiskreft (kolangiokarcinom) søker deltakere på steder i Illinois.

Byer i Illinois

Offisiell studietekst (engelsk)

A Study of PHST001 in Advanced Solid Tumors

  • University of Chicago Medical Center, Chicago
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06840886

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

  • City of Hope - Chicago Cancer Center (Site 128), Zion
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07265674

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • University Chicago Medicine, Chicago
  • Carle Cancer Center, Urbana
  • Midwestern Regional Medical Center, City of Hope Chicago, Zion
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05732831

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

  • Rush University Medical Center, Chicago
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 21. jul. 2026 · NCT07717437

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

  • University Of Chicago Medical Center, Chicago
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT05874414

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  • The University of Chicago Medical Center - Oncology, Chicago
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT07169734

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chicago
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

The Dragon PLC Trial (DRAGON-PLC)

  • Rush University Medical Center, Chicago
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 15. mai 2025 · NCT06914648

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.